Becoming Children With Perinatal Anoxo-Ischemic Encephalopathy Without Indication of Therapeutic Hypothermia
NCT03744481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68
Last updated 2019-11-01
Summary
There are 3 levels of severity of anoxo-ischemic encephalopathy (EAI): mild, moderate and severe. Therapeutic hypothermia is beneficial in children with moderate EAI. It is ineffective in severe EAI and may be deleterious if there is no EAI. He continues to question his interest in light EAIs.
There are few studies on the becoming of children with a mild anoxic-ischemic encephalopathy and not set hypothermia.
The main hypothesis of the study is that term newborns with anoxo-ischemic encephalopathy who did not require therapeutic hypothermia have normal psychomotor development at 2 years.
Conditions
- Anoxic-Ischemic Encephalopathy
Interventions
- OTHER
-
Questionaire
Evaluation of psychomotor development in children with mild EAI without indication of therapeutic hypothermia. Precise analysis of the type (motor, sensory, language, epilepsy) and the severity of sequelae by sending a questionnaire to parents. Investigation of early, clinical and paraclinical prognostic factors of good or bad neurodevelopmental outcome. Evaluation of the height-weight growth and the cranial perimeter
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 2 Years
- Max Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-19
- Primary Completion
- 2019-08-02
- Completion
- 2019-08-02
Countries
- France
Study Locations
More Related Trials
-
Is Feeding During Therapeutic Hypothermia Safe and Can Improve Outcomes in Infants With Hypoxic-ischaemic Encephalopathy
NCT06394453 ·Status: RECRUITING ·Phase: NA
-
Cool Prime Comparative Effectiveness Study for Mild HIE
NCT04621279 ·Status: RECRUITING
-
Moderate Hypothermia in Neonatal Hypoxic Ischemic Encephalopathy
NCT02826941 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy
NCT00817401 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hypothermia Therapy in Pediatric Cardiac Intensive Care Unit for Suspected for Brain Injury
NCT02395276 ·Status: UNKNOWN ·Phase: NA
-
Amnioinfusion for Intrauterine Neuroprotection
NCT05513690 ·Status: UNKNOWN ·Phase: NA
-
Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)
NCT02349672 ·Status: COMPLETED
-
Build a Decision Aid Tool to Help Emergency Intensive Care Specialists in the Context of Hypoxic Ischemic Encephalopathy
NCT05114070 ·Status: COMPLETED
-
Reno-protective Effect of Brain Cooling in Newborn With Hypoxia
NCT02683915 ·Status: COMPLETED
-
Continuous Versus Bolus Feeding in Neonates With Hypoxic Ischemic Encephalopathy
NCT06447155 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of Hypothermia to Treat Neonatal Hypoxic-Ischemic Encephalopathy
NCT00890409 ·Status: COMPLETED ·Phase: PHASE3
-
Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy
NCT03163589 ·Status: UNKNOWN ·Phase: PHASE3
-
Magnetic Resonance Imaging and Spectroscopy Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy
NCT01481207 ·Status: COMPLETED
-
Hypothermia Enhanced by Magnesium Sulphate
NCT02499393 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mesenchymal Stem Cells With Cooling Therapy for Infants With Hypoxic-Ischemic Encephalopathy
NCT07018739 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
NCT01732146 ·Status: COMPLETED ·Phase: PHASE3
-
Optimising Newborn Nutrition During Therapeutic Hypothermia.
NCT03278847 ·Status: COMPLETED
-
Neurodevelopmental Impact of Treatment in Hypothyroxinaemia of Prematurity.
NCT06346236 ·Status: COMPLETED
-
Neonatal Hypoxic Ischemic Encephalopathy : Safety and Feasibility Study of a Curative Treatment With Autologous Cord Blood Stem Cells
NCT02881970 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Does Placenta Pathology Predict Outcome of Neonates With Hypoxic Ischemic Encephalopathy?"
NCT03284528 ·Status: COMPLETED
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
NCT05778188 ·Status: RECRUITING ·Phase: PHASE2
-
Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy
NCT06810284 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Pilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic Encephalopathy
NCT00620711 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy
NCT06522581 ·Status: RECRUITING ·Phase: PHASE1
-
Prognostic Value of Arterial Spin Labeling Brain Perfusion MRI in Term Neonates With Hypoxic-ischemic Encephalopathy
NCT04325230 ·Status: COMPLETED ·Phase: NA